LON:BTEK Holdings Information

LON:BTEK is an equity ETF with a total of 264 individual holdings. The top holdings are Gilead Sciences stock at 7.52%, Amgen at 7.13%, Vertex Pharmaceuticals at 6.19%, Regeneron Pharmaceuticals at 6.12%, and Alnylam Pharmaceuticals at 5.26%.

Total Holdings

264

Top 10 Percentage

45.44%

Asset Class

Equity

ETF Category

Health Care

Assets

410.81M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.52%	371,727
2	AMGN	Amgen Inc.	7.13%	141,993
3	VRTX	Vertex Pharmaceuticals Incorporated	6.19%	92,569
4	REGN	Regeneron Pharmaceuticals, Inc.	6.12%	62,216
5	ALNY	Alnylam Pharmaceuticals, Inc.	5.26%	67,177
6	AZN	AstraZeneca PLC	4.74%	349,327
7	INSM	Insmed Incorporated	2.35%	107,868
8	ARGX	argenx SE	2.12%	18,682
9	BIIB	Biogen Inc.	2.02%	86,772
10	SMMT	Summit Therapeutics Inc.	1.98%	439,699
11	INCY	Incyte Corporation	1.66%	114,286
12	ILMN	Illumina, Inc.	1.62%	93,767
13	RPRX	Royalty Pharma plc	1.53%	248,783
14	UTHR	United Therapeutics Corporation	1.43%	26,631
15	SNY	Sanofi	1.42%	166,123
16	MEDP	Medpace Holdings, Inc.	1.35%	16,970
17	ONC	BeOne Medicines Ltd.	1.34%	24,522
18	TEM	Tempus AI, Inc.	1.34%	99,232
19	NBIX	Neurocrine Biosciences, Inc.	1.33%	58,431
20	VTRS	Viatris Inc.	1.26%	692,958
21	ASND	Ascendis Pharma A/S	1.19%	35,822
22	BNTX	BioNTech SE	1.14%	58,985
23	BMRN	BioMarin Pharmaceutical Inc.	1.12%	113,227
24	MRNA	Moderna, Inc.	1.10%	228,338
25	EXEL	Exelixis, Inc.	1.04%	161,011

As of Aug 18, 2025

Showing 25 of 264

Subscribe to see the full list

Upgrade Now